Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Apr;149(4):491.
doi: 10.1001/jamadermatol.2013.2846.

Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials--reply

Joel M Gelfand, Shuwei Wang, Junko Takeshita, Andrew D Robertson, Gerald G Krueger, Kristina Callis Duffin, Abby S Van Voorhees
Comment

Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials--reply

Joel M Gelfand et al. JAMA Dermatol. 2013 Apr.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Gelfand JM, Wan J, Callis Duffin K, et al. Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting. Arch Dermatol. Apr;148(4):487–494. - PMC - PubMed
    1. Chambers CJ, Parsi KK, Schupp C, Armstrong AW. Patient-centered online management of psoriasis: a randomized controlled equivalency trial. J Am Acad Dermatol. Jun;66(6):948–953. - PMC - PubMed
    1. Yeung H, Wan J, Van Voorhees AS, et al. Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. J Am Acad Dermatol. Jul 28; - PMC - PubMed
    1. Griffiths CE, Strober BE, van de Kerkhof P, et al. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med. Jan 14;362(2):118–128. - PubMed
    1. saurat JH, Stingl G, Dubertret L, et al. Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION) Br J Dermatol. 2008 Mar;158(3):558–566. - PubMed